I

IMMILS (Private limited company)

BE 0466.287.215 Active ●Huzenblek 22, 2381 Ravels

IMMILS is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0466.287.215. It was founded on 17-06-1999. Its registered office is in Ravels. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 8 821 and a loss of € 3 793. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.

Information last updated on 08-10-2026.

Company information

Status
Active
Enterprise number
BE 0466.287.215
VAT registered
No
Founded
17-06-1999
Latest accounts
2025
Employees
-
Region
Flanders
Establishments
1
Filing record
On time 3 of 4 years
Peppol e-invoicing
Not registered
Registered office
Huzenblek 22, 2381 Ravels
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
2110001 Etude, mise au point de la production des principes actifs destinés à la fabrication de médicaments
68201 Location et exploitation de biens immobiliers résidentiels propres ou loués, sauf logements sociaux
82100 Activités de service de bureau et de soutien administratif

Key figures of IMMILS

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -3 793+17 %€ -4 593-40 %€ -3 276-9 %€ -2 995
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 8 821-30 %€ 12 614-27 %€ 17 208-16 %€ 20 483
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 45 8490 %€ 45 7960 %€ 45 8930 %€ 45 696
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -2 900+24 %€ -3 793-48 %€ -2 569+10 %€ -2 851
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
1 mandate on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
Janssen Pharmaceutica 2340 Beerse
PFIZER MANUFACTURING BELGIUM 2870 Puurs-Sint-Amands
Organon Heist 2220 Heist-op-den-Berg
Kaneka Belgium 2260 Westerlo
DE CEUSTER MESTSTOFFEN 2280 Grobbendonk
CAPSUGEL BELGIUM 2880 Bornem
MEDICA 2550 Kontich
Novartis Manufacturing 2870 Puurs-Sint-Amands
Looking for more information about IMMILS?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is IMMILS still active? Yes. The Crossroads Bank for Enterprises lists IMMILS as active.

What is the VAT number of IMMILS? IMMILS is not registered for VAT. Its enterprise number is 0466.287.215.

When was IMMILS founded? IMMILS was founded on 17-06-1999.

What is the address of IMMILS? The current registered office of IMMILS is Huzenblek 22, 2381 Ravels.

When did IMMILS last file annual accounts? The latest annual accounts of IMMILS were filed on 27-08-2026.

Does IMMILS file its annual accounts on time? IMMILS filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2023.

Is IMMILS financially healthy? Addrly gives IMMILS a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is IMMILS profitable? The annual accounts of IMMILS for 2025 show a loss of € 3 793.

What is the equity of IMMILS? The equity of IMMILS was € 8 821 at the close of the 2025 financial year.

Who are the directors of IMMILS? The annual accounts of IMMILS record 1 mandate. The name, role and dates are visible with a free account.

Can IMMILS receive Peppol e-invoices? IMMILS is not registered on the Peppol network at the moment.

What does IMMILS do? The main activity of IMMILS is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data